MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Amoxicillin Oral Suspension Sugar Free BP (Athlone) (Reach) | |
New | Aprepitant SCP | |
New | Brooke | |
New | Brooklynn | |
New | Cequa | |
New | Chlorpromazine Hydrochloride Injection, USP (Hikma) | |
New | Cholfen Eye Ointment | |
New | Cipla Lenalidomide | |
New | Korsuva | |
New | Lacoress | |
New | Pharmacor Mycophenolate Powder for Oral Suspension | |
New | Sitaglo | |
New | Ultra Nature Selancy | |
New | Vizo-PF Dorzolatim | |
Reinstated | Acarbose Viatris | |
Reinstated | Amoxycillin/Clavulanic Acid 500/125 Apotex | |
Reinstated | APO-Amoxycillin and Clavulanic Acid 875/125 | |
Revised | Acamprosate Viatris | Nature and Contents of Container, Product Name change |
Revised | Acquin | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Adcetris | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Adenosine Juno | Adverse Effects (Undesirable Effects) |
Revised | Adesan | Nature and Contents of Container |
Revised | Adesan HCT | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | AKM Dabigatran | TGA Date |
Revised | Alcaine Eye Drops 0.5% | Fertility, Pregnancy and Lactation |
Revised | Amclavox Duo 500/125, Amclavox Duo Forte 875/125 | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Amikacin SXP | Special Warnings and Precautions for Use |
Revised | Anagrelide APOTEX | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Anpec | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose |
Revised | APO-Alendronate | Name of Medicine, Physicochemical Properties, Qualitative and Quantitative Composition, Sponsor |
Revised | APO-Betahistine | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation |
Revised | APOHealth Nausea Relief | Pharmaceutical Form |
Revised | APO-Olanzapine ODT | Sponsor |
Revised | APO-Olmesartan/Amlodipine/HCTZ | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Perindopril Arginine/Amlodipine | Overdose |
Revised | APO-Piroxicam | Sponsor |
Revised | APO-Quinapril | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | APO-Sumatriptan | TGA Date |
Revised | APX-Amoxicillin/Clavulanic Acid | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APX-Olmesartan | Adverse Effects (Undesirable Effects) |
Revised | APX-Olmesartan/HCTZ | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | APX-Ramipril | TGA Date |
Revised | APX-Sotalol | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Arianna 1 | TGA Date |
Revised | Ativan | List of Excipients, Pharmaceutical Form |
Revised | Avsartan | Adverse Effects (Undesirable Effects) |
Revised | Avsartan HCT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Azapin | TGA Date |
Revised | Betaferon | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Bexsero | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Bortezomib Accord | Adverse Effects (Undesirable Effects) |
Revised | Bortezomib-Teva | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Cabometyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Calutex | Adverse Effects (Undesirable Effects) |
Revised | Campral | Pharmaceutical Form |
Revised | Chemists' Own Anti-inflammatory Pain Relief | Adverse Effects (Undesirable Effects) |
Revised | Chemists' Own Procalm | Pharmaceutical Form |
Revised | Cinacalcet Viatris | Pharmaceutical Form |
Revised | Cipla Imatinib Adult | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Comirnaty (Tris/Sucrose Presentation) | Shelf Life |
Revised | Comirnaty Original/Omicron BA.1 | Shelf Life |
Revised | Cordilox SR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose |
Revised | Coumadin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Curosurf | TGA Date |
Revised | DBL Dexamethasone Sodium Phosphate Injection | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DBL Sulfamethoxazole 400 mg and Trimethoprim 80 mg | Pharmaceutical Form, Product Name change |
Revised | DBL Tobramycin Injection BP | Dose and Method of Administration |
Revised | Dexamethasone Viatris | Nature and Contents of Container, Pharmaceutical Form, Product Name change |
Revised | Dexmethsone | Adverse Effects (Undesirable Effects) |
Revised | Dinasane | TGA Date |
Revised | Diphereline | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Doryx | TGA Date |
Revised | Dynastat | Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, New contraindication |
Revised | Dysport | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Entocort | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use |
Revised | Entresto | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Escitalopram GH | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Esopreze | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Evusheld | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Feldene, Feldene-D | Fertility, Pregnancy and Lactation, New contraindication |
Revised | Femolet | List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Fludara Oral | Fertility, Pregnancy and Lactation, Nature and Contents of Container, Product Name change |
Revised | Foscavir | Special Warnings and Precautions for Use |
Revised | Galafold | TGA Date |
Revised | Grisovin | Sponsor |
Revised | Hypnovel | TGA Date |
Revised | Hyqvia | Special Warnings and Precautions for Use |
Revised | Ibiamox | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Ibupane | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Special Warnings and Precautions for Use |
Revised | Imatinib GH | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Inovelon | TGA Date |
Revised | Isoptin | Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Overdose |
Revised | Isoptin SR | Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Overdose |
Revised | Jardiance | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Jinarc | TGA Date |
Revised | Kanuma | Sponsor, TGA Date |
Revised | Keppra Oral | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Kiovig | Special Precautions for Storage |
Revised | Lamivudine Alphapharm | Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties |
Revised | Linezolid Kabi | Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Lithicarb | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Lyrica | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Marevan | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Mayne Pharma Doxycycline Capsules | List of Excipients |
Revised | Mesasal | Qualitative and Quantitative Composition |
Revised | Metex XR 1000 | Sponsor |
Revised | Metex XR 500 | Sponsor |
Revised | Mobilis | List of Excipients, Overdose |
Revised | MS Mono | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Naloxone SXP | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nexium | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Nexium Hp7 | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Nexium IV | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Noumed Fluoxetine | Nature and Contents of Container |
Revised | Nuvaxovid | Dose and Method of Administration, Shelf Life |
Revised | Olmekar | Adverse Effects (Undesirable Effects) |
Revised | Olmertan | Adverse Effects (Undesirable Effects), List of Excipients, Qualitative and Quantitative Composition |
Revised | Olmertan Combi | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use, Sponsor |
Revised | Olmesartan/Amlodipine APOTEX | Adverse Effects (Undesirable Effects) |
Revised | Ondansetron ODT Lupin | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | Ondansetron Viatris | Nature and Contents of Container, Pharmaceutical Form, Product Name change |
Revised | Opsumit | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Ovestin Cream | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ovestin Ovula | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pantoprazole Sandoz 40mg Powder for Injection | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Pariet 10 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pfizer (Australia) Daunorubicin Injection | Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Pfizer (Australia) Tobramycin Injection BP | Dose and Method of Administration |
Revised | Pfizer (Australia) Tobramycin PF | Dose and Method of Administration |
Revised | Pharmacor Dabigatran | TGA Date |
Revised | Pharmacor Dimethyl Fumarate | Adverse Effects (Undesirable Effects) |
Revised | Pharmacor Gliclazide MR | TGA Date |
Revised | Pharmacor Olmesartan Amlodipine | Adverse Effects (Undesirable Effects) |
Revised | Pharmacor Olmesartan HCTZ | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pharmacor Telmisartan | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | PipTaz-AFT | TGA Date |
Revised | Pregabalin-DRLA | Adverse Effects (Undesirable Effects),Boxed Warnings, Special Warnings and Precautions for Use |
Revised | Prilace | TGA Date |
Revised | ProQuad | Adverse Effects (Undesirable Effects), Overdose |
Revised | Quilonum SR | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Rasagiline Lupin | Product Name change |
Revised | Remicade | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Remifentanil Viatris | Nature and Contents of Container, Product Name change, Special Precautions for Storage |
Revised | Reminyl | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Resotrans | TGA Date |
Revised | Rimycin | Nature and Contents of Container |
Revised | Ronapreve | Adverse Effects (Undesirable Effects), Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Ropivacaine Kabi | Overdose |
Revised | Salpraz Heartburn Relief (reformulation 2) | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Simipex XR | TGA Date |
Revised | SMOFlipid | TGA Date |
Revised | Solavert | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Solifenacin Viatris | Nature and Contents of Container, Product Name change |
Revised | Sotacor | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Spikevax | TGA Date |
Revised | Strensiq | TGA Date |
Revised | Sylvant | TGA Date |
Revised | Synthamin | Special Precautions for Storage |
Revised | Tamate | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tobramycin Viatris | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Trimethoprim Viatris | Nature and Contents of Container, Product Name change |
Revised | Triumeq | Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Valprease | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Visipaque Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Voltaren Ophtha | Fertility, Pregnancy and Lactation |
Revised | Voltaren Rapid 50 | Fertility, Pregnancy and Lactation |
Revised | Vzole | TGA Date |
Revised | Xalatan | Adverse Effects (Undesirable Effects) |
Revised | Xarelto | Adverse Effects (Undesirable Effects) |
Revised | Yescarta | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Zeldox | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zonegran | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Deleted | BCG Culture SSI | |
Deleted | CardioChol | |
Deleted | Cilicaine Syringe 1.5 | |
Deleted | ProbioZyme |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au